In order to assess the behavior of IFNγR2- and Jak1-mutant tumor cells in vivo, we subcutaneously implanted mutant or WT tumor cells into C57BL/6 mice and tracked tumor growth. This evidence concerns the gene JAK1 and neoplasm.